SureTrader
Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US Listed > Biotechs >

BIONDVAX PHARMACUETICALS LTD (BVXV)

BVXV RSS Feed
Add BVXV Price Alert      Hide Sticky   Hide Intro
Moderator: TechKim, midastouch017
Search This Board: 
Last Post: 8/19/2017 11:27:16 AM - Followers: 11 - Board type: Free - Posts Today: 0

BiondVax is an innovative biopharmaceutical company developing a Universal Flu Vaccine, designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains. BiondVax’s technology utilizes a unique, proprietary combination of conserved and common epitopes from influenza virus proteins to activate both arms of the immune system for a cross-protecting and long-lasting effect. BiondVax has successfully completed two Phase II and two Phase I/II clinical trials of the lead product, the Multimeric-001 Universal Flu Vaccine. In all four trials, the vaccine was shown to be safe and immunogenic, successfully stimulating both humoral and cellular immune responses. Pre-clinical and clinical results support that Multimeric-001 is a universal flu vaccine that in the event of a pandemic could be administered as a pandemic primer, to prepare the population immunologically while the pandemic strain-specific vaccine is manufactured.
BVXV
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BVXV News: Report of Foreign Issuer (6-k) 08/17/2017 05:01:45 PM
BVXV News: BiondVax Receives Additional Grant Funding 08/14/2017 08:00:00 AM
BVXV News: Report of Foreign Issuer (6-k) 07/20/2017 05:02:05 PM
BVXV News: BiondVax Reports Positive Phase 2b Clinical Trial Results for its Universal Flu Vaccine 07/20/2017 06:30:00 AM
BVXV News: BiondVax Signs Lease Agreement for Mid-Size Commercial Facility to Manufacture Universal Flu Vaccine 07/18/2017 07:30:00 AM
PostSubject
#200  Sticky Note Company Presentation: midastouch017 04/28/17 08:51:59 AM
#1  Sticky Note Amazing video http://www.biondvax.com/128084/Video TechKim 06/19/15 10:11:28 AM
#252   Analysts are projecting that the stock will reach midastouch017 08/19/17 11:27:16 AM
#251   I wouldn't be surprised if GSK buys it. midastouch017 08/18/17 01:14:52 PM
#250   Why would you pick GSK? Just curious! TechKim 08/18/17 12:14:33 PM
#249   I wouldn't be surprised if GSK buys it. buckiii2 08/17/17 04:19:51 PM
#248   I am not betting on it. I TechKim 08/17/17 02:10:24 PM
#247   Coming of age, Israel biotech sector gets ready midastouch017 08/17/17 10:28:32 AM
#246   I get your message TechKim but midastouch017 08/17/17 08:20:06 AM
#245   Kill the competition. Remember Edison and Tesla? It TechKim 08/17/17 06:27:46 AM
#244   I do not see the logic in midastouch017 08/16/17 01:42:50 AM
#243   Buy out! Then buried. TechKim 08/15/17 08:23:54 PM
#242   I agree with you. buckiii2 08/15/17 09:56:52 AM
#241   Big pharma could also bury the product. midastouch017 08/15/17 12:25:47 AM
#240   Maybe and maybe not. If governments are involved TechKim 08/14/17 07:55:30 PM
#239   IMHO yes, in due time! midastouch017 08/14/17 08:21:20 AM
#238   BiondVax Receives Additional Grant Funding midastouch017 08/14/17 08:19:01 AM
#237   Will big pharma buy it? buckiii2 08/11/17 03:48:29 PM
#236   Interesting company overall. The final question is will TechKim 08/09/17 03:23:59 PM
#235   First time member of this message board. Golden Warrior 08/04/17 08:42:20 AM
#234   $9.27 TechKim 08/04/17 08:41:55 AM
#233   BVXV: Positive Results From Phase 2b Trial of midastouch017 08/02/17 08:07:02 AM
#232   Looking good Cbdpotential 07/20/17 09:58:50 AM
#231   Almost sounds to good to be true. TechKim 07/20/17 09:17:05 AM
#230   BVXV: BiondVax Reports Positive Phase 2b Clinical Trial midastouch017 07/20/17 07:45:25 AM
#229   Wow. Positive news. Great!!! ?? midastouch017 07/20/17 07:22:52 AM
#228   BiondVax to set up new Jerusalem manufacturing plantIsraeli midastouch017 07/19/17 02:04:18 PM
#227   Biondvax Pharmaceuticals: New Funds To Support M-001’s Phase midastouch017 07/18/17 09:04:58 AM
#226   BiondVax Signs Lease Agreement for Mid-Size Commercial Facility midastouch017 07/18/17 08:31:02 AM
#225   The safety trial will not meet the life TechKim 06/29/17 02:45:37 PM
#224   If all goes well and according midastouch017 06/29/17 02:34:15 PM
#223   On a very erratic and generalized population figure TechKim 06/29/17 01:51:22 PM
#222   BiondVax's CEO Provides First Half 2017 General Corporate Update midastouch017 06/29/17 01:06:35 AM
#221   Flu viruses frequently and unpredictably mutate. Since it midastouch017 06/19/17 01:55:46 PM
#220   European Investment Bank (EIB) Supports Late-Stage Development and midastouch017 06/19/17 09:35:24 AM
#219   Methinks that 60% positive would midastouch017 06/16/17 11:28:35 AM
#218   Taking profits is always a good deal. Pigs TechKim 06/16/17 10:35:58 AM
#217   I took some. Time will tell midastouch017 06/15/17 11:24:05 PM
#216   Into the final days of the second quarter. TechKim 06/15/17 02:02:54 PM
#215   BVXV: Immunogenicity Results From Phase 2b Trial of midastouch017 06/02/17 02:10:56 PM
#214   BiondVax Announces First Quarter 2017 Financial Results and Update midastouch017 05/30/17 07:44:42 AM
#212   According to First Call, the current consensus target midastouch017 05/15/17 02:17:14 PM
#211   A very active BVXV day in TASE midastouch017 05/14/17 10:34:28 AM
#210   That is usually a good sign when the TechKim 05/11/17 09:15:11 AM
#209   Very wise strategy TechKim. Made midastouch017 05/11/17 08:46:32 AM
#208   Well not to throw an iron in the TechKim 05/10/17 02:50:45 PM
#207   There is no doubt that there is midastouch017 05/10/17 02:10:25 PM
#206   I thought I saw the volume building. Of TechKim 05/09/17 07:59:11 PM
#205   But what did you see in that midastouch017 05/09/17 03:11:43 PM
#204   It was the TEVA exchange. Link says timed TechKim 05/09/17 02:35:40 PM
#203   Dead end link midastouch017 05/09/17 02:08:25 PM
#202   BVXV waking up. TEVA showing some excitement? http://www.tase.co.il/Eng/Manageme TechKim 05/09/17 02:04:44 PM
PostSubject